- Q1 2024 MaxCyte Inc Earnings Call TranscriptMay 07, 2024$3.93 (+0.51%)Earnings
- Q4 2023 MaxCyte Inc Earnings Call TranscriptMar 12, 2024$3.98 (+0.25%)Earnings
- Q3 2023 MaxCyte Inc Earnings Call TranscriptNov 08, 2023$3.35 (-1.47%)Earnings
- Preliminary Q3 2023 MaxCyte Inc Earnings Call TranscriptOct 04, 2023$3.27 (+9.00%)Earnings
- Q2 2023 MaxCyte Inc Earnings Call TranscriptAug 09, 2023$4.36 (-2.68%)Earnings
- MaxCyte Inc at William Blair Growth Stock Conference TranscriptJun 08, 2023
- Q1 2023 MaxCyte Inc Earnings Call TranscriptMay 10, 2023$4.65 (-0.64%)Earnings
- Q4 2022 MaxCyte Inc Earnings Call TranscriptMar 15, 2023$4.2 (+2.69%)Earnings
- MaxCyte Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q3 2022 MaxCyte Inc Earnings Call TranscriptNov 09, 2022$6.1 (-9.36%)Earnings
- MaxCyte Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 MaxCyte Inc Earnings Call TranscriptAug 10, 2022$5.68 (+3.65%)Earnings
- MaxCyte Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 MaxCyte Inc Earnings Call TranscriptMay 09, 2022$4.84 (-4.35%)Earnings
- Q4 2021 MaxCyte Inc Earnings Call TranscriptMar 22, 2022$6.9 (+3.45%)Earnings
- MaxCyte Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- MaxCyte Inc at ShareSoc Webinar TranscriptFeb 08, 2022
- MaxCyte Inc at Proactive ONE2ONE Virtual Forum TranscriptDec 02, 2021
- MaxCyte Inc at Stephens Investment Conference (Virtual) TranscriptNov 29, 2021
- Q3 2021 MaxCyte Inc Earnings Call TranscriptNov 10, 2021$10.7 (-7.68%)Earnings
- Q2 2021 MaxCyte Inc Earnings Call TranscriptSep 13, 2021Earnings
Q1 2024 MaxCyte Inc Earnings Call Transcript
Good day and thank you for standing by, and welcome to the MaxCyte first quarter of 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Eric Abdo, Investor Relations. Please go ahead.
Good afternoon, everyone. Thank you for participating in today's conference call. On the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer; and Douglas Swirsky, Chief Financial Officer. Earlier today, Maxim released financial results for the first quarter ended March 31, 2024 a copy of the press release is available on the company's website.
Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements and actual
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)